Zdenek Vrozina Profile picture
Mar 6 16 tweets 3 min read Read on X
A new preprint proposes an interesting mechanism for Long COVID - a link between gut dysbiosis - microbial extracellular vesicles - systemic inflammation - neuroinflammation.
This is not just correlation. The authors also test functional models.🧵
The main idea - after SARS-CoV-2 infection, patients may develop a persistent alteration of the gut microbiome. This does not only mean a different bacterial composition, but also the production of different signaling particles - so-called gut microbiota-derived extracellular vesicles (GMEVs).
These vesicles are microscopic membrane particles carrying bacterial cargo. Proteins, lipids, nucleic acids, and other immunologically active molecules. The authors propose that they may transmit inflammatory signals from the gut to the rest of the body.
In a cohort of people with Long COVID, the researchers found persistent microbiome alterations up to 12 months after infection. Certain microbial patterns were associated with neurological symptoms such as memory problems, concentration difficulties, or brain fog.
A strong part of the study - the authors did not only analyze patients. They transplanted microbiota from patients with neurological symptoms into germ-free mice. The mice developed impaired intestinal barrier integrity, behavioral changes, and signs of neuroinflammation.
This moves the study beyond typical observational. It does not just say these patients have a different microbiome, but suggests that microbiota associated with Long COVID can transfer pathological effects, at least in experimental models.
The second step is even more interesting. The researchers isolated microbial extracellular vesicles directly from patient stool samples. These vesicles were then tested on intestinal epithelial cells, macrophages, and human iPSC-derived microglia.
The result?
Vesicles from Long COVID samples triggered inflammatory programs, including inflammasome activation and cytokine production (eg IL-1β, TNF), and also activated microglia. In simple words, a microbial product alone produced effects relevant to the neuroimmune axis.
The authors also show that these vesicles can disrupt intestinal barrier integrity. This is important because it could create a feedback loop.
Dysbiosis - more inflammatory vesicles - weaker barrier - more microbial signals entering circulation - more inflammation.
When these vesicles were chronically administered orally to mice, the animals showed microbiome shifts, intestinal inflammation, increased systemic inflammatory markers, and glial activation in the brain. This supports the concept of the gut–immune–brain axis.
This is also interesting in the context of HIV pathogenesis.
In HIV we already know a model where gut damage - microbial translocation - chronic immune activation - blood–brain barrier disruption - neuroinflammation. This study suggests a related principle for Long COVID.
Mechanistic detail. In HIV the key event is early destruction of gut immune cells, particularly CD4 T cells. Here the focus is on microbial extracellular vesicles as mobile carriers of inflammatory signals, which is a relatively new concept.
Another notable factor highlighted in the study is BAFF, a B-cell activating factor. It was increased across several experimental systems and may reflect broader immune dysregulation involving chronic inflammation and B-cell activation!
So this study does not prove that Long COVID has a single cause or that everything can be explained by gut mechanisms. Rather, it suggests that gut-driven neuroinflammation may be a plausible component of the syndrome.
Still, this is one of the more mechanistically interesting studies on Long COVID in recent months. As a strong working hypothesis that dysbiotic microbiota and their vesicles may help sustain chronic inflammation and neurological symptoms after COVID-19.
Aranguren at al., Microbiota-derived extracellular vesicles link intestinal dysbiosis to neuroimmune activation in long COVID. biorxiv.org/content/10.648…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Zdenek Vrozina

Zdenek Vrozina Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ZdenekVrozina

Mar 6
A new PET study in patients with treatment-resistant depression suggests something important - ketamine does not just act generally on glutamate - it appears to reshape AMPA receptor density in specific brain circuits. @DavidJoffe64 🧵
The researchers used [11C]K-2, a tracer that can visualize AMPA receptors in the living human brain.
That matters because AMPA receptors are a key part of glutamatergic signaling.
For years researchers have suspected that ketamine’s rapid antidepressant effects depend on them. This study tries to show that directly in humans, not just in animal models.
Read 18 tweets
Mar 6
A new study looked at long-term taste dysfunction after COVID-19.
Researchers combined psychophysical taste tests, biopsies of tongue papillae, and gene-expression analysis in taste cells from patients with persistent symptoms more than a year after infection🧵
One striking observation - in most patients, taste buds were not structurally destroyed. Under the microscope, both taste receptor cells and the nerve fibers that normally innervate them were still present.
Yet many patients had lost the ability to detect specific tastes. The most affected were sweet, umami and bitter - the three taste modalities that share the same intracellular signaling pathway in so-called Type II taste cells.
Read 17 tweets
Mar 4
A very interesting 2026 study compares classic ME/CFS, post-COVID ME/CFS like (PCS-CFS), and MS.
It doesn’t just measure antibodies - it tests their functional effects on cells (in vitro).
And the takeaway? Post-COVID does not look identical🧵
Researchers isolated IgG antibodies from patients and exposed endothelial cells to them.
They analyzed mitochondrial structure, cellular energetics, inflammatory cytokines, immune complex proteomics
This allows biological comparison across groups.
Classic ME/CFS
IgG from a subset of patients induced mitochondrial fragmentation and metabolic adaptation.
This resembles chronic cellular stress - not acute energy failure.
Read 13 tweets
Mar 3
Two recent studies suggest that Long COVID may involve long-term neurobiological remodeling - even after mild infection.
One examined the brain under cognitive load.
The other looked at it at rest.
Together, they point to a persistent shift in network organization!🧵
In the first study (Barnden et al.), the key issue was not where the brain activates -
but how its networks coordinate under mental exertion.
The largest differences appeared during cognitive load.
The regulatory switching system began to fail.
The main systems involved were
the salience network - deciding what matters, and executive control circuits - sustaining performance.
And after repeated cognitive effort, the disruption became more pronounced.
That matches the lived experience
I can manage for a while - then it falls apart.
Read 17 tweets
Mar 2
In this group of people who self-identified as having Long COVID and were willing to complete an online survey, Long COVID is very long-lasting - around 20 months after symptom onset, only about 5% were fully back to baseline.🧵
The median duration of symptoms was about 20 months.
Only 5% of patients fully recovered.
About 59% never had a symptom-free day.
Most common course patterns
constant symptoms 45%
fluctuating ~27%
relapsing ~10%
Read 17 tweets
Mar 2
This paper is a systematic review summarizing 10 studies focused on cardiovascular findings after COVID.
The main message is - Long COVID is associated with measurable changes in the heart and blood vessels🧵
Systematic review according to PRISMA 2020
PubMed, Scopus, Web of Science
1/2020 - 3/2024 (updated 11/2025)
Out of 412 records, 10 high-quality studies were selected.
Subclinical myocardial dysfunction (eg impaired strain/GLS), arrhythmias, endothelial/vascular dysfunction, increased arterial stiffness, occasionally persistent biomarkers (troponin), and newly diagnosed hypertension.
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(